These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2261600)

  • 1. Intrinsic B lymphocyte defect in untreated patients with Hodgkin's disease.
    Griesinger F; Bergmann L; Barot-Ciorbaru R; Mitrou PS
    Cancer Immunol Immunother; 1990; 32(4):256-60. PubMed ID: 2261600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.
    Romagnani S; Del Prete GF; Maggi E; Bellesi G; Biti G; Rossi Ferrini PL; Ricci M
    J Clin Invest; 1983 May; 71(5):1375-82. PubMed ID: 6602150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired T- and B-cell functions in patients with Hodgkin's disease. Reduced mitogenic responsibility and Il-2 production is not caused by defective CD4+-cells.
    Bergmann L; Mitrou PS; Demmer-Dieckmann M; Ruhmann FT; Weidmann E
    Cancer Immunol Immunother; 1987; 25(1):59-64. PubMed ID: 3496158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective in vitro immunoglobulin production in response to pokeweed mitogen in patients with Hodgkin's disease pretreatment and in remission.
    Dickinson AM; McLachlan SM; Jacobs EA; Fail B; Proctor SJ
    Clin Immunol Immunopathol; 1986 Nov; 41(2):281-9. PubMed ID: 2945682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous and Concanavalin A-induced suppressor activity in control and Hodgkin's disease patients.
    Akbar AN; Jones DB; Wright DH
    Br J Cancer; 1984 Mar; 49(3):349-56. PubMed ID: 6231045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of Ig classes and IgG subclasses among human B cells activated by Nocardia opaca-delipidated cell mitogen or by pokeweed mitogen.
    Bich-Thuy LT; Ciorbaru-Barot R; Revillard JP
    Scand J Immunol; 1985 Jun; 21(6):531-8. PubMed ID: 3875142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte abnormalities in untreated patients with Hodgkin's disease.
    Holm G; Mellstedt H; Björkholm M; Johansson B; Killander D; Sundblad R; Söderberg G
    Cancer; 1976 Feb; 37(2):751-62. PubMed ID: 1082795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of human B lymphocytes by Nocardia-delipidated cell mitogen and derived fractions from N. opaca. Structure-activity relationship.
    Barot-Ciorbaru R; Brochier J; Miyawaki T; Preud'Homme JL; Petit JF; Bona C; Taniguchi N; Revillard JP
    J Immunol; 1985 Nov; 135(5):3277-83. PubMed ID: 3930601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired B-lymphocyte reactivity in patients with Hodgkin's disease and non-Hodgkin-lymphomas.
    Rühl H; Enders B; Bur M; Sieber G
    Blut; 1981 May; 42(5):271-81. PubMed ID: 7016220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of polyclonally activated human peripheral B cells by aggregated IgG and by IgG-binding factors: differential effect on IgG subclass synthesis.
    Bich-Thuy LT; Revillard JP
    J Immunol; 1984 Aug; 133(2):544-9. PubMed ID: 6610704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenic T and B lymphocytes and their mitogenic response in untreated Hodgkin's disease.
    Han T; Minowada J; Subramanian V; Barcos M; Kim U
    Cancer; 1980 Feb; 45(4):767-74. PubMed ID: 6965606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of polyclonal B cell activation by IgG-binding factors. Requirement for T cells.
    Lê thi Bich-Thuy ; Revillard JP
    Eur J Immunol; 1985 Jan; 15(1):96-9. PubMed ID: 3155689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of human blood lymphocyte by different polyclonal B cell activators of bacterial and plant origin: production of IgM, IgG and IgA estimated by the ELISA method.
    Tlaskalová-Hogenová H; Bártová J; Mrklas L; Mancal P; Broukal Z; Barot-Ciorbaru R; Novák M; Hanikýrová M
    Folia Microbiol (Praha); 1985; 30(3):258-66. PubMed ID: 3891552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Sternberg-Reed, and related cells in Hodgkin's disease: an immunohistological study.
    Dorreen MS; Habeshaw JA; Stansfeld AG; Wrigley PF; Lister TA
    Br J Cancer; 1984 Apr; 49(4):465-76. PubMed ID: 6370286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of human IgA-B-cell maturation by IgA-binding factors requires T cells.
    Millet I; Revillard JP
    Int Arch Allergy Appl Immunol; 1988; 87(4):367-70. PubMed ID: 3265931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel lymphokine derived from human IgG Fc receptor-bearing B cells: its suppressive effect on activated T and B lymphocytes including tumour cells in vitro.
    Suzuki T; Park YH; Miyama-Inaba M; Masuda T; Saji H; Nagata I; Uchino H
    Immunology; 1985 Jul; 55(3):427-36. PubMed ID: 3160654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of interferon-alpha on immunoglobulin synthesis by human B cells.
    Peters M; Ambrus JL; Zheleznyak A; Walling D; Hoofnagle JH
    J Immunol; 1986 Nov; 137(10):3153-7. PubMed ID: 3021846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [T and B lymphocytes in chronic lymphocytic leukemia and Hodgkin's disease. Electron microscopic and immunologic studies].
    Cohnen G
    Veroff Pathol; 1975; (0):1-99. PubMed ID: 49138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human T-independent B lymphocyte mitogen extracted from Nocardia opaca.
    Brochier J; Bona C; Ciorbaru R; Revillard JP; Chedid L
    J Immunol; 1976 Nov; 117(5 Pt 1):1434-9. PubMed ID: 1087313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.